On Tuesday, Stifel analysts reaffirmed a Buy rating and a $14.00 price target for ZoomInfo Technologies stock (NASDAQ: GTM), which currently trades at $10.31. According to InvestingPro data ...

On Tuesday, Stifel analysts reaffirmed a Buy rating and a $14.00 price target for ZoomInfo Technologies stock (NASDAQ: NASDAQ:GTM), which currently trades at $10.31. According to InvestingPro data, ...

Barclays boosted their price objective on shares of ZoomInfo Technologies from $9.00 to $11.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 13th.

Analysts at Stifel are bullish about Illumina, Inc.’s (NASDAQ:ILMN) prospects despite the stock capitulating 36% year to date. On May 28, the analysts reiterated a Buy rating on the stock and a ...

On May 24, analysts at Stifel reaffirmed their Buy rating and price target of $48 for Bicara Therapeutics Inc. (NASDAQ:BCAX). This follows the American Society of Clinical Oncology (ASCO ...

Analysts at Stifel are bullish about Illumina, Inc.’s (NASDAQ:ILMN) prospects despite the stock capitulating 36% year to date. On May 28, the analysts reiterated a Buy rating on the stock and a $135 ...

The reiteration of the Buy rating and the $375 price target indicates Stifel’s confidence in Salesforce’s strategy and its execution in expanding its Data and AI capabilities. Salesforce’s stock ...